Pharma co Boehringer Ingelheim partners with blockchain firm for diabetes care – Ledger Insights

  • Care announced it has partnered with Boehringer Ingelheim Pharmaceuticals Inc to create the Diabetes Care Administration Network.
  • The digital network aims to streamline treatment for type 2 diabetes patients.
  • The Estonia based firm’s technology will be applied to the type 2 diabetes-focused network to allow patients to coordinate their care with doctors and families easily.

Read full article: